SCHEMBL22997607

SCHEMBL22997607

Cc1c(-n2cnc(-c3nc(NC4CCN(Sc5cn(C)cn5)CC4)ncc3C(F)(F)F)c2)ccnc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 17/20 0.44
▸ CDK2 P24941 17/20 0.44
▸ CDK1 P06493 12/20 0.40
▸ CCNB1 P14635 12/20 0.40
▸ CDK4 P11802 11/20 0.40
▸ CCND1 P24385 11/20 0.40
▸ CCND3 P30281 11/20 0.40
▸ CDK6 Q00534 11/20 0.40
▸ CCNT1 O60563 7/20 0.40
▸ CDK9 P50750 7/20 0.40
▸ CDK7 P50613 6/20 0.40
▸ CCNH P51946 6/20 0.40
▸ MNAT1 P51948 6/20 0.40
▸ CCNK O75909 2/20 0.36
▸ CDK12 Q9NYV4 2/20 0.36
▸ PSEN1 P49768 1/20 0.33
▸ PSEN2 P49810 1/20 0.33
▸ APH1B Q8WW43 1/20 0.33
▸ NCSTN Q92542 1/20 0.33
▸ APH1A Q96BI3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22997642 0.85 CCNE1 (0.43) CCNE1CDK2CDK1CCNB1CDK4
SCHEMBL22997649 0.85 CCNE1 (0.53) CCNE1CDK2CDK1CCNB1CDK4
SCHEMBL30449551 0.84 CCNE1 (0.59) CCNE1CDK2CDK1CCNB1CDK4
SCHEMBL22976947 0.84 CCNE1 (0.59) CCNE1CDK2CDK1CCNB1CDK4
SCHEMBL22997713 0.78 CCNE1 (0.49) CCNE1CDK2CDK1CCNB1CDK4
SCHEMBL27026916 0.76 CDK2 (0.47) CCNE1CDK2CDK1CCNB1CDK4
SCHEMBL22997720 0.76 CCNE1 (0.55) CCNE1CDK2CDK1CCNB1CDK4
SCHEMBL22997698 0.76 CCNE1 (0.45) CCNE1CDK2CDK1CCNB1CDK4
SCHEMBL22997709 0.75 CCNE1 (0.52) CCNE1CDK2CDK1CCNB1CDK4
SCHEMBL22976931 0.75 CCNE1 (0.58) CCNE1CDK2CDK1CCNB1CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021030537-A1 IMIDAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS INCYTE CORPORATION (US) 2021-02-18 — — WO disclosed
Send feedback